Metabolic syndrome patients with hypertriglyceridemia exhibited a nonsignificant increase in serum IL-1β as compared to metabolic syndrome patients without abnormally high triglyceride values (Figure 3(d)). Here, IL1B is linked to hypertriglyceridemia.